VectorBuilder and Lir Therapeutics Partner to Develop Next-Generation AAV Capsids for Clinical Applications
VectorBuilder and Lir Therapeutics Partner to Develop Scalable, AI-Engineered AAV Capsids for Gene Therapy VectorBuilder, a global provider of gene delivery technologies, and Lir Therapeutics, a biotechnology company focused on…
Cardio Diagnostics Launches In-House Testing at New CLIA-Certified Laboratory in Iowa City
Cardio Diagnostics Launches In-House CLIA-Certified Laboratory to Advance Precision Cardiovascular Testing Cardio Diagnostics Holdings, Inc., an artificial intelligence-driven precision cardiovascular medicine company, has announced the official launch of its new…
bioAffinity Technologies and AvMEDICAL Sign Nationwide Federal Distribution Agreement for CyPath® Lung
bioAffinity Technologies Expands Government Healthcare Reach Through Distribution Agreement with AvMEDICAL for CyPath Lung bioAffinity Technologies, Inc., a biotechnology company focused on developing noninvasive diagnostic solutions for the early detection…
Enveda Announces Positive Phase 1 Results for Exercise-Inspired Oral Drug ENV-308
Enveda Reports Positive Phase 1 Results for ENV-308, an Oral Therapy Designed to Support Long-Term Metabolic Health As the use of GLP-1 medications continues to expand among adults in the…
Stuart Therapeutics Appoints David Jakeman as Chief Financial Officer
Stuart Therapeutics Appoints David Jakeman as Chief Financial Officer to Support Late-Stage Development and Commercialization Plans Stuart Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing first-in-class collagen-reparative therapeutics for…
Ingenia Therapeutics Lists on KOSDAQ to Advance Next-Generation Vascular Antibody Pipeline
Ingenia Therapeutics Begins KOSDAQ Trading to Advance Vascular-Targeted Therapy Pipeline Ingenia Therapeutics, a clinical-stage biotechnology company focused on developing next-generation vascular-targeted therapies, has announced that its shares have begun trading…
Nanochon Receives Panama Approval to Begin First-in-Human Chondrograft™ Clinical Trial
Nanochon Secures Panamá Health Ministry Approval to Begin First-in-Human Chondrograft™ Clinical Study Radiation Detection Company (RDC), a long-established provider of occupational radiation dosimetry services, has announced the launch of Radiant,…
Radiation Detection Company Launches Radiant to Enhance Real-Time Safety in High-Exposure Clinical Settings
Radiation Detection Company Launches Radiant Real-Time Dosimetry Solution to Enhance Radiation Safety in Medical Settings Radiation Detection Company (RDC), a long-established provider of occupational radiation dosimetry services, has announced the…
FDA Approves LEROCHOL® Autoinjector and Expands Its Indication
FDA Approves LEROCHOL Autoinjector for Once-Monthly Self-Administration in Patients With High Cholesterol LIB Therapeutics, Inc. (LIB), a privately held biopharmaceutical company focused on helping high-risk patients achieve and maintain recommended…
SINOVAC Reports Unaudited First-Half 2026 Financial Results
Sinovac Reports 12.9% Revenue Growth in First Half of 2026 as Overseas Vaccine Business Expands Sinovac Biotech Ltd., a leading biopharmaceutical company in China, has announced the filing of its…
Canopy Growth Announces 2026 Annual Meeting Proxy Materials, Urges Shareholders to Vote
Canopy Growth Distributes 2026 Annual Meeting Materials and Urges Shareholders to Vote Ahead of September 25 Meeting Canopy Growth Corporation, a global company focused on the cannabis sector, has announced…
Zai Lab and argenx Report Positive Phase 3 ALKIVIA Results for Efgartigimod in Autoimmune Myositis
Zai Lab and argenx Report Positive Phase 3 Results for VYVGART Hytrulo in Autoimmune Myositis Zai Lab Limited and argenx have announced positive topline results from the ALKIVIA Phase 3…